StoxFortis Healthcare vs Krishna Institute of Medical Sciences: share price & financials comparison
NSE: FORTIS vs KIMS · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Fortis Healthcare vs Krishna Institute of Medical Sciences at a glance
Fortis Healthcare (FORTIS) has a market capitalisation of ₹57,679 Cr, against ₹30,645 Cr for Krishna Institute of Medical Sciences (KIMS). Over the past year Krishna Institute of Medical Sciences has returned +1.8%, compared with -25.0% for Fortis Healthcare. On valuation, Fortis Healthcare trades at a lower P/E of 55.5 versus 144.3. Fortis Healthcare earns a higher return on equity (9.9% vs 5.4%). Fortis Healthcare comes out ahead on size, valuation, profitability and financial health. Krishna Institute of Medical Sciences comes out ahead on growth, momentum and technicals. Across the scored metrics below, Fortis Healthcare leads on 8 and Krishna Institute of Medical Sciences on 9. On StoxGud's 10-point checklist, Fortis Healthcare scores 4/10 and Krishna Institute of Medical Sciences scores 4/10.
| Metric | Fortis Healthcare | Krishna Institute of Medical Sciences |
|---|---|---|
| Size | ||
| Market cap | ₹57,679 Cr | ₹30,645 Cr |
| Revenue (latest FY) | ₹9,128 Cr | ₹3,905 Cr |
| Net profit (latest FY) | ₹1,042 Cr | ₹241 Cr |
| Valuation | ||
| P/E | 55.5 | 144.3 |
| P/B | 5.50 | 7.79 |
| Dividend yield | 0.13% | 0.68% |
| Profitability | ||
| Return on equity | 9.9% | 5.4% |
| Net profit margin | 10.5% | 4.6% |
| Operating margin | 22.2% | 19.3% |
| Growth | ||
| Revenue growth (YoY) | +17.3% | +39.9% |
| Net profit growth (YoY) | -3.0% | +11.8% |
| Revenue CAGR (multi-year) | +17.8% | +24.0% |
| Financial health | ||
| Debt to equity | 0.30 | 0.90 |
| Momentum | ||
| 1-month return | +1.0% | +2.8% |
| 1-year return | -25.0% | +1.8% |
| 3-year CAGR | +27.5% | +25.0% |
| 5-year CAGR | +22.6% | +24.9% |
| 10-year CAGR | +16.8% | — |
| Distance from 52W high | -25.1% | -14.2% |
| Technicals | ||
| RSI (14) | 62 | 80 |
| Price vs 200-day avg | -14.2% | -0.1% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Fortis Healthcare | Krishna Institute of Medical Sciences |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✗ | ✗ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✗ | ✓ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 4/10 | 4/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Fortis Healthcare or Krishna Institute of Medical Sciences?
Fortis Healthcare has a market cap of ₹57,679 Cr and Krishna Institute of Medical Sciences has a market cap of ₹30,645 Cr as of 13 Nov 2026.
Which has a lower P/E, Fortis Healthcare or Krishna Institute of Medical Sciences?
Fortis Healthcare has the lower P/E: Fortis Healthcare trades at 55.5 and Krishna Institute of Medical Sciences at 144.3.
Which gave better returns in the last year, Fortis Healthcare or Krishna Institute of Medical Sciences?
Krishna Institute of Medical Sciences did better: Fortis Healthcare returned -25.0% and Krishna Institute of Medical Sciences returned +1.8% over one year.
What is the difference between Fortis Healthcare and Krishna Institute of Medical Sciences?
Both are NSE-listed companies in Healthcare. Fortis Healthcare is about 1.9 times the size of Krishna Institute of Medical Sciences by market cap. In the latest financial year Fortis Healthcare reported revenue of ₹9,128 Cr and Krishna Institute of Medical Sciences ₹3,905 Cr. Operating margin is 22.2% for Fortis Healthcare and 19.3% for Krishna Institute of Medical Sciences. Debt to equity is 0.30 for Fortis Healthcare and 0.90 for Krishna Institute of Medical Sciences.
Which is better, Fortis Healthcare or Krishna Institute of Medical Sciences?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Fortis Healthcare leads on 8 and Krishna Institute of Medical Sciences on 9. Fortis Healthcare is ahead on size, valuation, profitability and financial health. Krishna Institute of Medical Sciences is ahead on growth, momentum and technicals. On StoxGud's rules-based checklist Fortis Healthcare scores 4/10 and Krishna Institute of Medical Sciences scores 4/10. This is information, not advice: consult a SEBI-registered adviser before investing.